Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed Almradi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 26, 2020
Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel DiseaseAhmed Almradi, Jurij Hanzel, Rocio Sedano, et al.
Digestive Diseases and Sciences|February 26, 2021
Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-AnalysisJurij Hanzel, Ahmed Almradi, Alexandra C Istl, et al.
Inflammatory Bowel Diseases|June 28, 2021
Disease Activity Indices for Pouchitis: A Systematic ReviewRocio Sedano, Tran M Nguyen, Ahmed Almradi, et al.
Journal of Crohn'S & Colitis|November 10, 2021
Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled TrialsAhmed Almradi, Rocio Sedano, Malcolm Hogan, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2021
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trialsAhmed Almradi, Christopher Ma, Geert R D'Haens, et al.
Gastroenterology|February 21, 2021
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical TrialsChristopher Ma, Rocio Sedano, Ahmed Almradi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 26, 2020
Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel DiseaseAhmed Almradi, Jurij Hanzel, Rocio Sedano, et al.
Digestive Diseases and Sciences|February 26, 2021
Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-AnalysisJurij Hanzel, Ahmed Almradi, Alexandra C Istl, et al.
Inflammatory Bowel Diseases|June 28, 2021
Disease Activity Indices for Pouchitis: A Systematic ReviewRocio Sedano, Tran M Nguyen, Ahmed Almradi, et al.
Journal of Crohn'S & Colitis|November 10, 2021
Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled TrialsAhmed Almradi, Rocio Sedano, Malcolm Hogan, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2021
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trialsAhmed Almradi, Christopher Ma, Geert R D'Haens, et al.
Gastroenterology|February 21, 2021
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical TrialsChristopher Ma, Rocio Sedano, Ahmed Almradi, et al.
Pageof 1